Omeros Corporation Annoucnes Positive Trial Results for OMS721
Seattle-based Omeros Corporation (NASDAQ:OMER)’s has surged after the bell and is currently 5% in the green after the company announced positive data from its Phase 2 clinical trial of OMS721 for the treatment of kidney disorders. Statistical significance (p = 0.017) was achieved on key endpoints of improvement in renal function. The company also said it had a meeting with the FDA to pursue the authorities to get a breakthrough therapy designation for OMS721 in immunoglobulin A (IgA) nephropathy, also known as Berger’s disease. OMS721 is also being evaluated in a Phase 3 program for patients suffering atypical hemolytic uremic syndrome (aHUS) and in a Phase 2 program for patients with thrombotic microangiopathies (TMAs), including hematopoietic stem cell transplant-associated TMAs and thrombotic thrombocytopenic purpura. Investors are paying attention to the news as the said diseases currently have no approved treatments and patients ultimately have to choose dialysis. A total of six funds from our database were long Omeros Corporation (NASDAQ:OMER) at the end of the second quarter.
Follow Omeros Corp (NASDAQ:OMER)
Follow Omeros Corp (NASDAQ:OMER)
Rogers Communications Gets New CEO
Rogers Communications Inc. (USA) (NYSE:RCI) is on investors’ radar today after the company said Guy Laurence would step down as the CEO of the company. Mr. Laurence will be replaced by Joseph Natale, who left the company a year ago when Rogers Communications determined it wanted its CEO based in Western Canada instead of Toronto. Mr. Laurence had joined the Toronto-based company in 2013, when he left Vodafone Group PLC. Edward Rogers, Rogers’ deputy chairman, said in statement that Guy’s leadership moved the company forward, re-established growth, and introduced new innovative programs. Rogers Communications recently made major changes to its magazine operations amid a decline in advertising revenue as the company struggles to migrate to the digital space from the traditional media. Mario Gabelli’s GAMCO Investors is one of 19 funds tracked by Insider Monkey that held stakes in Rogers Communications Inc. (USA) (NYSE:RCI) at the end of the second quarter.
Follow Rogers Communications Inc (NYSE:RCI)
Follow Rogers Communications Inc (NYSE:RCI)
Kratos Defense Wins $12.6 Million Contract
Kratos Defense & Security Solutions, Inc (NASDAQ:KTOS) shares have gained over 4% so far today after the company said it had been awarded $12.6 million contract with Defense Innovation Unit Experimental (DIUx), the Silicon Valley-based defense innovation unit which was started by Secretary of Defense Ashton Carter, to increase cooperation between the US military and commercial warfare innovation space. The awarded contract is in coordination with STRATCOM and the Strategic Capabilities Office to explore the use of high speed drones in fully autonomous or semi-autonomous roles to support fourth and fifth generation fighter aircrafts. From our database, nine funds owned shares of Kratos Defense & Security Solutions, Inc (NASDAQ:KTOS) at the end of the second quarter.
Follow Kratos Defense & Security Solutions Inc. (NASDAQ:KTOS)
Follow Kratos Defense & Security Solutions Inc. (NASDAQ:KTOS)
Disclosure: none